INFbeta therapy for COVID-19 the new SNG001 drug /

INFbeta therapy for COVID-19 the new SNG001 drug /

Show other versions (1)
Saved in:
Bibliographic Details
Other Authors: Holgate, S. T. (Speaker)
Format: Electronic Audio
Language:English
Published: London : Henry Stewart Talks, 2020.
Series:Henry Stewart talks. Biomedical & life sciences collection. Interviews on Covid-19.
Subjects:
Antiviral agents > Development.
Clinical trials.
Coronavirus infections > Chemotherapy.
COVID-19 (Disease) > Treatment.
Interferon.
Antiviral Agents > administration & dosage.
Clinical Trials as Topic.
Coronavirus infections.
COVID-19 > drug therapy.
Drug Delivery Systems.
Interferon-beta > administration & dosage.
Interferon-beta > therapeutic use.
Nebulizers and Vaporizers.
SARS-CoV-2.
Treatment Outcome.
Online Access:https://hstalks.com/bs/4301
Series
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000nim a2200000 a 4500
001 HST8172
003 UkLoHST
006 m o h
007 cr nna||||||||
007 sr |mnnnnnzne|
008 200604s2020 enk|||||o||h||||||||eng d
028 5 0 |a 8172  |b Henry Stewart Talks 
035 |a (UkLoHST)4301 
040 |a UkLoHST  |b eng  |c UkLoHST 
100 1 |a Holgate, S. T.  |4 spk  |9 89446 
245 1 0 |a INFbeta therapy for COVID-19  |h [electronic resource] :  |b the new SNG001 drug /  |c Stephen Holgate. 
246 3 |a INFβ therapy for COVID-19 : the new SNG001 drug 
246 3 |a Interferon-beta therapy for COVID-19 : the new SNG001 drug 
260 |a London :  |b Henry Stewart Talks,  |c 2020. 
300 |a 1 online resource (1 streaming audio file (10 min.)). 
490 1 |a Interviews on Covid-19,  |x 2056-452X 
500 |a Audio interview. 
500 |a Title from title frames. 
505 0 |a Contents: Why INFβ was chosen as a therapy for COVID-19 -- Previous use of INFβ by inhalation -- Safety of INFβ as a therapy -- SNG001 mode of delivery -- SNG001 clinical trials and future prospects. 
506 |a Access restricted to subscribers. 
538 |a Mode of access: World Wide Web. 
650 0 |a Antiviral agents  |x Development.  |9 89447 
650 0 |a Clinical trials.  |9 89448 
650 0 |a Coronavirus infections  |x Chemotherapy.  |9 89449 
650 0 |a COVID-19 (Disease)  |x Treatment.  |9 89450 
650 0 |a Interferon.  |9 89451 
650 2 |a Antiviral Agents  |x administration & dosage.  |9 89452 
650 2 |a Clinical Trials as Topic.  |9 89453 
650 2 |a Coronavirus infections.  |9 89454 
650 2 |a COVID-19  |x drug therapy.  |9 89455 
650 2 |a Drug Delivery Systems.  |9 89456 
650 2 |a Interferon-beta  |x administration & dosage.  |9 89457 
650 2 |a Interferon-beta  |x therapeutic use.  |9 89458 
650 2 |a Nebulizers and Vaporizers.  |9 89459 
650 2 |a SARS-CoV-2.  |9 89460 
650 2 |a Treatment Outcome.  |9 89461 
830 0 |a Henry Stewart talks.  |p Biomedical & life sciences collection.  |p Interviews on Covid-19.   |9 89462 
856 4 0 |u https://hstalks.com/bs/4301 
856 4 2 |u https://hstalks.com/bs/p/1060/  |3 Series 
999 |c 214040  |d 214039 

Similar Items